The vaccines being produced won't be distributed until the FDA confirms the plant's conditions meet all standards for safety, effectiveness and manufacturing quality.
The award announced by the Department of Health and Human Services is the biggest yet from "Operation Warp Speed" to cover testing and manufacturing of a potential vaccine for the novel coronavirus.
Aptevo Therapeutics (APVO) was spun out of Emergent BioSolutions (EBS) last summer and seems underappreciated for its combination of commercial products and R&D pipeline.
